🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementPancreatitis risk assessment — anyone have experience? Page 6

Pancreatitis risk assessment — anyone have experience?

JenPlateau Wed, Jul 2, 2025 at 6:56 PM 29 replies 1,958 viewsPage 6 of 6
BethLabQueen
Senior Member
1,234
5,678
May 2024
Virginia
Online
Jul 24, 2025 at 11:29 PM#26
Dr.NateNeph said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

Agreed, and one caution: a single measurement is not a measurement. Anything that moves day to day needs a trend before it means anything at all.

Ask again with the specifics and you will get a better answer than this one.

8 6maya_sedona, stefan_berlin, Dr.EM_Chicago and 5 others
Reply Quote Save Share Report
andrew_nyc
Member
534
2,345
Apr 2024
New York, NY
Jul 27, 2025 at 9:54 AM#27
Dr.NateNeph said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

Thank you for spelling out the reasoning rather than just the conclusion.

9 7Dr.NateNeph, PharmD_Rodriguez, julia.endo and 6 others
Reply Quote Save Share Report
jim_asheville
Member
289
1,234
Aug 2024
Asheville, NC
Jul 29, 2025 at 8:18 PM#28

From the other side of the consultation, briefly. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

10 8NurseAsh_DET, BenResearch_OR, MikeKY_noInsulin and 7 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
PeptideChemSF
Senior Member
1,890
9,012
Jan 2024
San Francisco, CA
Aug 1, 2025 at 6:41 AM#29
jim_asheville said:
The useful move here is to separate what is established from what is widely repeated.

This matches mine closely enough to be worth saying so out loud. Posting only so the count is not one.

11 9ricardo_MIA, BrianDallas92, labquiet_amy and 8 others
Reply Quote Save Share Report
JenPlateau
Member
234
890
Nov 2024
Missouri
Aug 3, 2025 at 5:02 PM#30

Closing the loop on my own question.

Coming back a few months on. It held. Nothing dramatic to report, which is the report.

33 6sarah_nash92, FitDadDave, RunnerRach and 30 others
Reply Quote Save Share Report
1456

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register